Trial intelligence / Profile preview

Multiple-dose GRT0151Y for post-tonsillectomy pain

2005-001656-21Phase 2Completed

Sponsor
Grünenthal GmbH
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of axomadol in postoperative pain (5 arms), sponsored by Grünenthal GmbH. Primary endpoint: Time-averaged pain intensity while swallowing on Days 4 and 5 (TAPI-48). Started Jun 2005; status: completed.

02

Drugs

axomadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2005-001656-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001656-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call